MAKE SURE YOUR DENTIST IS AN ADA MEMBER!: ADA Members Adhere to Strict Code of Ethics and Conduct. You should make sure you are SEEING AN ADA MEMBER DENTIST! Visit ADA Find-A-Dentist to Find One Near YOU
Ninth District Headquarters Office - Hawthorne, NY

2026 Ninth District President

Dr. Bharat Joshi

RENEW YOUR MEMBERSHIP TODAY!

3 EASY WAYS TO PAY 1 ONLINE: nysdental.org/renew 2 MAIL: Return dues stub and payment 3 PHONE: 1-800-255-2100

NYSDAPAC

NYSDA’s fully owned and operated Political Action Committee. With your support, NYSDAPAC will strengthen our political influence and ensure your voice is heard statewide and beyond.

2026 Member Benefits Guide

Explore Your Member Benefits — The 2026 Member Benefits Guide is now available! See everything NYSDA offers and get a quick overview with our At-A-Glance one-pager.

Member Assistance Program (MAP)

Life comes with challenges—but your FREE, confidential Member Assistance Program (MAP) is here to help. Available to you, your household, and your staff, MAP offers one-on-one short-term counseling plus resources for mental health, stress management, financial wellness, and life coaching. Download the app today to get started.

Welcome to the Ninth District Dental Association

The Ninth District Dental Society was formed in 1909 and renamed to the Ninth District Dental Association in 2002. We have a membership of over 1500 dentists in 5 counties: Westchester, Rockland, Dutchess, Orange and Putnam.

In its quest to serve both the public and the profession, the Ninth District embodies the highest ideals.

The mission of the 9th District Dental Association is to serve and support its members and the public by improving the oral health of our community through Advocacy, Continuing Education and Camaraderie.


The 9th Board approved creating a High School Career Day video to promote the dental field as a whole! Here's the link: 

 

https://drive.google.com/file/d/1Kk10wFBk5MXT4CeitvzzCSXKPrVFzz73/view?usp=drive_link

 

Please share it with any Principal or Guidance Counselor you may have a relationship with!


Come join your colleagues!

Don't forget to Register!! 

 

September's General Meeting

Wednesday, September 23, 2026
8:00 am - 3:30 pm

Crowne Plaza Hotel
3 Executive Blvd.
Suffern, NY 10901


(845) 357-4800

Dr. Matthew Malek will present:
"Diagnosis and Treatment Planning: Endodontic Inflammation, Infection and Fractures"
"Root Resorption: Types, Diagnosis, and Management" 
and
Iatrogenic Incidents: Perforation, Instrument Separation, and Sodium Hypochlorite Accident"

ON-SITE CHECK-IN BEGINS AT 8:00 AM

We Hope to See You There!!

Bharat Joshi, D.D.S.
President

The latest from FDA

Apr 4, 2024


UpdatesPublic health emergency response and other updates from FDA since our last MCMi e-mail include:
More FDA press announcements
 

Artificial intelligence update

FDA publishes AI paper

FDA published a new paper, Artificial Intelligence and Medical Products: How CBER, CDER, CDRH, and OCP are Working Together (PDF), which outlines specific focus areas regarding the development and use of AI across the medical product lifecycle.
The multi-center effort from FDA’s CDER, Center for Devices and Radiological Health (CDRH), Center for Biologics Evaluation and Research (CBER), and the Office of Combination Products (OCP) supports approaches to the safe, secure, ethical, and trustworthy development and use of AI. (March 15, 2024)
Graphic representing artificial intelligence (AI) and SARS-CoV-2, the virus that causes COVID-19
Related links

COVID-19 update

FDA authorizes new long-acting monoclonal antibody for pre-exposure prevention of COVID-19 in certain immunocompromised individuals

Coronavirus update
FDA issued an Emergency Use Authorization (PDF) for Pemgarda (pemivibart) for the pre-exposure prophylaxis (prevention) of COVID-19 in certain adults and adolescents (12 years of age and older weighing at least 40 kilograms [about 88 pounds]).
Pemgarda is authorized for individuals:
  • who are not currently infected with SARS-CoV-2 and who have not had a known recent exposure to an individual infected with SARS-CoV-2;
  • and who have moderate-to-severe immune compromise due to a medical condition or due to taking immunosuppressive medications or treatments and are unlikely to mount an adequate immune response to COVID-19 vaccination.
More information:
 

Drug shortage updates

Vials

New public portal

FDA launched a new portal for patients, consumers, and health care professionals to report potential drug shortage issues directly into CDER’s NextGen system without creating a NextGen account. (March 18, 2024)

HHS releases white paper focused on preventing drug shortages 

The U.S. Department of Health and Human Services (HHS) released a white paper, Policy Considerations to Prevent Drug Shortages and Mitigate Supply Chain Vulnerabilities in the United States, highlighting steps HHS has taken to prevent and mitigate drug shortages and proposing additional solutions for policymakers to consider. 
FDA recognizes that a robust, resilient and safe drug supply chain is essential for public health and national security. We remain committed to partnering across government, academia, and industry to strengthen and diversify the supply chain, further address drug shortages and ensure Americans continue to have access to drugs that are of high quality, safe and effective. (April 2, 2024) 

Latest News Around the Ninth


Around the Ninth District